Clinical Trial Update: Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic [NA]

View source ↗

Summary

A completed clinical trial update evaluating the pharmacokinetics and pharmacodynamics of combining imipenem with amikacin for ventilator-associated pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Amikacin (amikacin)
• Imipenem/Cilastatin (imipenem/cilastatin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Ventilator Associated Pneumonia | NA | Status: COMPLETED